Eton Pharmaceuticals reports record Q3 2026 revenue, up 158% year over year
FROM THE WIRE · FINANCE.YAHOO.COM
This article first appeared on GuruFocus. Release Date: November 05, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Revenue grew 158% year over year to $57.9 million, a record quarter. Adjusted EBITDA…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishStrong revenue growth and a wider pipeline offset higher R&D spending and weaker ET700 study efficacy.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Revenue of 57.9 million dollars, up 158% year over year.
- 02Adjusted EBITDA margin of 49% in the quarter.
- 03Cash of 56 million dollars and pipeline expanded to nine programs.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets